Meta-analysis of the randomized controlled trials of the hemostatic efficacy and capacity of pathogen-reduced platelets

Dose of Prophylactic Platelet Transfusions and Prevention of Hemorrhage

(2010) Sherrill J. Slichter et al.   NEW ENGLAND JOURNAL OF MEDICINE

A systematic assessment of the quality of reporting for platelet transfusion studies

(2010) Meghan Delaney et al.   TRANSFUSION

A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology

(2010) J-P. Cazenave et al.   TRANSFUSION

Pathogen inactivation of platelet concentrates

(2010) H. W. Reesink et al.   VOX SANGUINIS

Buffy-coat-derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred?

(2010) H. Schrezenmeier et al.   VOX SANGUINIS

Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention

(2009) E. C. Vamvakas et al.   BLOOD

Cell viability during platelet storage in correlation to cellular metabolism after different pathogen reduction technologies

(2009) Susanne M. Picker et al.   TRANSFUSION

Limiting and detecting bacterial contamination of apheresis platelets: inlet-line diversion and increased culture volume improve component safety

(2009) Anne F. Eder et al.   TRANSFUSION

A randomized study of buffy coat platelets in platelet additive solution stored 1-5 versus 6-7 days prior to prophylactic transfusion of allogeneic haematopoietic progenitor cell transplant recipients

(2009) B. Diedrich et al.   VOX SANGUINIS

In vitrocomparison of platelet storage in plasma and in four platelet additive solutions, and the effect of pathogen reduction: a proposal for anin vitrorating system

(2009) P. F. van der Meer et al.   VOX SANGUINIS

A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia

(2008) N. M. Heddle et al.   BLOOD

A prospective observational cohort safety study of 5106 platelet transfusions with components prepared with photochemical pathogen inactivation treatment

(2008) Jean C. Osselaer et al.   TRANSFUSION

An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatment

(2008) J. C. Osselaer et al.   VOX SANGUINIS